Background: Localized actomyosin contraction couples with actin polymerization and cell-matrix adhesion to regulate cell protrusions and retract trailing edges of migrating cells. Although many cells migrate in collective groups during tissue morphogenesis, mechanisms that coordinate actomyosin dynamics in collective cell migration are poorly understood. Migration of Drosophila border cells, a genetically tractable model for collective cell migration, requires nonmuscle myosin-II (Myo-II). How Myo-II specifically controls border cell migration and how Myo-II is itself regulated is largely unknown. Results: We show that Myo-II regulates two essential features of border cell migration: (1) initial detachment of the border cell cluster from the follicular epithelium and (2) the dynamics of cellular protrusions. We further demonstrate that the cell polarity protein Par-1 (MARK), a serine-threonine kinase, regulates the localization and activation of Myo-II in border cells. Par-1 binds to myosin phosphatase and phosphorylates it at a known inactivating site. Par-1 thus promotes phosphorylated myosin regulatory light chain, thereby increasing Myo-II activity. Furthermore, Par-1 localizes to and increases active Myo-II at the cluster rear to promote detachment; in the absence of Par-1, spatially distinct active Myo-II is lost. Conclusions: We identify a critical new role for Par-1 kinase: spatiotemporal regulation of Myo-II activity within the border cell cluster through localized inhibition of myosin phosphatase. Polarity proteins such as Par-1, which intrinsically localize, can thus directly modulate the actomyosin dynamics required for border cell detachment and migration. Such a link between polarity proteins and cytoskeletal dynamics may also occur in other collective cell migrations.
Introduction
Cells that migrate during embryonic morphogenesis or adult wound healing often move as cohesive groups, in a process termed ''collective cell migration'' [1] . Because collective migration occurs in many cancers as part of the tumor invasion process [1, 2] , a better understanding of the mechanisms that regulate this mode of migration may provide critical insights into tumor invasion and metastasis. Border cell migration in the Drosophila ovary is a powerful genetic model system to identify and dissect conserved molecular pathways that control directed collective cell migration (reviewed in [3] ). During late oogenesis, the six to ten follicle cell-derived border cells form a cohesive group, detach from the follicle cell monolayer epithelium, and migrate w150 mm between the germline-derived nurse cells to the anterior border of the oocyte ( Figure 1A ; see also Figure S1A available online). Proteins that regulate the actin cytoskeleton, such as cofilin and the small GTPase Rac, are essential for proper border cell migration [4, 5] . Moreover, guidance signaling through the epidermal growth factor receptor (EGFR) and the platelet-derived growth factor/vascular-endothelial growth factor (PDGF/VEGF) receptor related (PVR) promotes Racdependent formation of actin-rich protrusions at the front of the border cell cluster [5] [6] [7] . However, a thorough understanding of how the cytoskeleton is dynamically modulated during border cell migration is still lacking.
We previously demonstrated that Par-1, a cell polarity protein and serine-threonine kinase, regulates several critical aspects of border cell migration-the proper detachment of the border cell cluster from the follicular epithelium and the directional extension of cell protrusions [8] . Par-1 is known to cooperate with other polarity proteins to establish static apical-basal cell polarity, especially in epithelia. Par-1 has also been implicated in regulation of microtubule stability, Wnt signaling, and neuronal migration [9] . We determined that border cell detachment depends on negative regulation of another polarity protein, Par-3/Bazooka (Baz), by Par-1 [8] . Detachment requires Par-1-dependent restriction of Par-3/Baz to apical domains of detaching border cells. It is not clear, however, whether mutually exclusive partitioning of Par-1 and Par-3/Baz is sufficient for border cell detachment. Moreover, other aspects of border cell migration such as protrusion direction, length, and morphology are independent of Par-3/Baz but dependent on Par-1 [8, 10] , suggesting that Par-1 controls these processes through other partners.
Nonmuscle myosin-II (Myo-II) regulates cell migration [11] by inducing localized contraction of the actin cytoskeleton, establishing migrating cell polarity, modulating cell adhesions, and retracting trailing edges. In Drosophila, Myo-II is required for epithelial remodeling and movement during tissue and organ formation, such as occurs during dorsal closure, gastrulation, and border cell migration [12, 13] . Myo-II contains two copies of each of three subunits: the Drosophila heavy chain (MHC) is Zipper (Zip), the essential light chain is myosin light chain-cytoplasmic (Mlc-c), and the myosin regulatory light chain (MRLC) is Spaghetti squash (Sqh). The latter is targeted by Rho-associated kinase (Rok; also known as ROCK) and myosin light chain kinase (MLCK) [11, 14] , which phosphorylate MRLC/Sqh at Thr-18/Ser-19 (Thr-19/Ser-20 in Drosophila). Phosphorylation of MRLC increases the ATPase activity of the MHC and stabilizes myosin-containing filaments [11] . Activation by Rok further helps localize Myo-II to cortical cell membranes and is required for Myo-II function in vivo [15] [16] [17] [18] . Conversely, myosin phosphatase dephosphorylates MRLC/Sqh to inactivate Myo-II [19] .
In this study, we show that active Myo-II modulates both border cell cluster detachment and the refinement of cellular protrusions important for cell motility. In turn, Par-1 promotes the localized phosphorylation and activation of Myo-II. We show that Par-1 activates Myo-II by phosphorylating and inhibiting the myosin phosphatase complex. Whereas myosin phosphatase is uniformly distributed, Par-1 is localized to the rear of the detaching cluster, resulting in phosphatase inhibition and Myo-II activation at the cluster rear. Our results thus show for the first time that a Par-1/Myo-II regulatory pathway connects dynamic cell polarity with cytoskeletal dynamics to regulate collective cell migration.
Results

Myo-II Is Required for Border Cell Detachment and Protrusion Dynamics
Previous studies found that global loss of sqh (Drosophila MRLC) throughout the ovary strongly inhibited border cell migration [13] . In addition, single border cells mutant for sqh extended long, abnormal protrusions [20] . These studies, however, did not specifically address which cells require Myo-II or whether Myo-II regulates other aspects of border cell migration. To further investigate Myo-II function in border cell migration, we performed mosaic clonal analysis using a sqh null allele, sqh AX3 [17] . Border cell clusters containing at least one mutant border cell exhibited migration defects and were found anywhere from 25% to 70% of the normal migration distance ( Figure 1B ; data not shown). These mutant border cells were usually located at the back of the cluster (68%, n = 28), similar to other mutants that disrupt border cell motility [6] . In most of these egg chambers, anterior epithelial follicle cells were also mutant ( Figure 1B ; data not shown). Only a few clusters were observed in which all border cells were mutant (13%, n = 32); in each case, the cluster failed to detach from the epithelium and did not move away from the anterior end of the egg chamber ( Figure 1B ). We then confirmed that activation of Myo-II is important. We performed mosaic clonal analysis with a strong mutant allele of rok, rok 2 [15] , which is a known Myo-II activator. We observed comparable migration defects in egg chambers with rok mosaic mutant clones (n = 15; data not shown). These results are consistent with a role for active Myo-II in border cells and possibly anterior follicle cells.
To better understand why border cells defective for Myo-II do not migrate, we performed live time-lapse imaging of egg chambers in culture [7] . Because completely mutant sqh or rok border cell clusters were difficult to obtain (data not shown), we knocked down the function of Myo-II in all border cells using the GAL4/UAS system. A dominant-negative form of Zip (DN-Zip), which lacks the MHC catalytic motor domain, disrupts the formation of functional Myo-II [21] . Expression of DN-Zip in border cells and follicle cells using the follicle cellspecific driver c306-GAL4 ( Figure S1A ) significantly inhibited border cell detachment and migration in fixed egg chambers ( Figures 1A and 1C) . Thus, loss of the MHC Zip is similar to loss of MRLC/Sqh in sqh loss-of-function mosaic clones or Sqh RNA interference (RNAi) (Figure 1 ). Using an alternative border cell driver, slbo-GAL4, we further confirmed that Myo-II was required in border cells ( Figure S1B ). The central polar cells trigger Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling to recruit surrounding cells to form the border cell cluster and stimulate their motility [3] . Specific knockdown of Myo-II in polar cells by upd-GAL4 did not disrupt border cell migration ( Figure S1C ).
In live egg chambers, control (wild-type) border cells extend protrusions in the direction of migration, detach from the epithelium, and migrate to the oocyte over the course of 4-6 hr (Movie S1) [7] . Control protrusions before detachment are longer in length and lifetime than those that extend after border cells detach and begin to migrate (Figures S1D-S1F). Expression of DN-Zip disrupted the ability of some border cells to properly detach from the follicle cell epithelium and move forward ( Figure 1D ; Movie S2). DN-Zip did not affect the direction of protrusion extension (data not shown). However, DN-Zip border cell clusters that did not detach initially had normal protrusions, but these protrusions failed to resolve into protrusions of shorter length and duration like in control (Figures S1E and S1F). Notably, DN-Zip border cell clusters that detached initially extended protrusions with normal characteristics but after detachment protrusions were slightly longer in length (p = 0.04; unpaired two-tailed t test) and had significantly longer lifetime (p = 0.001) than the control (Figures S1E and S1F).
Activated Myo-II Is Required Downstream of Par-1 in Border Cell Migration
Defects in border cell detachment were also found in border cells in which Par-1 function was disrupted, either by c306-GAL4-driven RNAi knockdown ( Figures 1A and 1C ) or lossof-function mosaic clones [8] . Moreover, previously published studies of border cells mutant for sqh [20] and par-1 [8] reported examples of similar, misshapen long protrusions. We hypothesized that Par-1 and Myo-II may act in the same pathway to regulate border cell migration. In support of this, we identified a genetic interaction between par-1 and sqh (Figure 2A ). Weak expression of RNAi transgenes for Par-1 or Sqh (UAS-RNAi driven by c306-GAL4) each mildly disrupted border cell migration. Coexpression of weak RNAi for both Par-1 and Sqh dramatically increased the migration defects by 2.5-fold over the expected additive phenotype. par-1 and rok also exhibited a genetic interaction ( Figure 2B ). Stronger RNAi knockdown of Par-1 (UAS-Par-1 RNAi driven by c306-GAL4 in a heterozygous par-1 mutant background) significantly disrupted border cell detachment, whereas Rok RNAi disrupted detachment less frequently. Coexpression of RNAi for both Par-1 and Rok enhanced the detachment defect to almost twice the expected additive phenotype. These results indicate that Rok and Par-1 both regulate border cell detachment, potentially through a common substrate such as Myo-II.
The interaction between par-1 and sqh led us to investigate whether Myo-II could suppress the migration defects caused by loss of par-1. We used a series of transgenes expressing MRLC/Sqh under the control of the endogenous sqh promoter [15, 17, 22] . These transgenes are either unmutated (wildtype), singly mutated at the primary phosphorylation site (Ser-21), or doubly mutated at the primary and secondary (Thr-20) phosphorylation sites. Phosphomimetic, active forms of Sqh (mutation to glutamic acid; E20E21 or E21) and nonphosphorylatable, inactive Sqh (mutation to alanine; A20A21) have been shown to respectively rescue or enhance phenotypes caused by loss of the Myo-II activator rok in Drosophila [15] .
Expression of a single copy of any of the sqh transgenes in a wild-type background did not disrupt border cell migration ( Figure S2A ). Neither nonphosphorylatable sqhA20A21 nor WT sqh transgenes suppressed the Par-1 RNAi phenotype ( Figure 2C ). Conversely, a single copy of either of the phosphomimetic mutant transgenes (sqhE21 or sqhE20E21) strongly suppressed the Par-1 RNAi migration defects ( Figure 2C ). Importantly, none of the transgenes suppressed the migration defects caused by disruption of Par-3/Baz ( Figure S2B ), a known target of Par-1 in polarized cells [23] and border cells [8] . Furthermore, sqh-E21 did not rescue the border cell motility or detachment defects found in mutants of two other genes known to regulate border cell migration ( Figures S2C  and S2D ). These results suggest that activated Myo-II is specifically required downstream of Par-1. In agreement with this, overexpression of Par-1 did not rescue the migration defects caused by Sqh RNAi ( Figure S2E ).
We next determined whether activation of endogenous Myo-II could suppress the phenotypes caused by disruption of Par-1 function. Activation of Myo-II can occur either by increasing Myo-II kinase levels or by inactivating myosin phosphatase [11] . Ectopic expression of the Myo-II kinases MLCK or Rok in vivo leads to greater phosphorylation of MRLC/Sqh and activation of endogenous Myo-II [11, 24] (see below). Conversely, myosin phosphatase inactivates Myo-II by dephosphorylating MRLC/Sqh and consists of a type 1 protein phosphatase catalytic subunit (PP1c), a subunit M20 of unknown function, and the substrate-specific myosin binding subunit Mbs (also known as MYPT). Therefore, inactivation of myosin phosphatase increases the activity of Myo-II in cells [19, 25] (see below). To inhibit myosin phosphatase function in vivo, we expressed an inhibitor of PP1c, nuclear inhibitor of PP1 (NIPP1) [26] , or Mbs RNAi. Increasing the levels of activated Myo-II in a WT background, either by overexpressing Myo-II kinases or inhibiting myosin phosphatase, disrupted both border cell migration and detachment from the epithelium ( Figure S2F ). Thus, border cells, like many migrating cells [11] , require precise levels and/or distribution of active Myo-II for normal movement. Nonetheless, overexpression of Myo-II kinases or inhibition of myosin phosphatase efficiently suppressed the Par-1 RNAi-induced border cell detachment and migration defects ( Figure 2D ). These results confirm that activation of Myo-II rescues the detachment and migration defects caused by loss of par-1.
Par-1 Regulates the Distribution and Dynamics of Myo-II in Border Cells
It has been noted that Myo-II accumulates at cortical membranes of migrating border cells [13] . Using time-lapse imaging, we examined the subcellular distribution of a functional GFP-tagged Sqh transgene driven by its own promoter (Sqh:GFP). This transgene rescues sqh mutant flies to viability and accurately reports the localization of Myo-II in vivo [22] . Sqh:GFP is highly expressed in live border cells throughout their migration (Movie S3) and accumulates in transient, intense fluorescent cortical puncta or ''foci'' ( Figure 3A ; Movie S4); these foci resembled those described in a variety of epithelia [12, [27] [28] [29] . Sqh:GFP foci were particularly evident where the cluster displayed an obvious change in morphology, such as at the cluster rear during detachment (Movie S3; see below). Control border cell clusters had an average of six foci per cluster with a median lifetime of 92 s ( Figures 3A, 3C , and 3D; Movie S4).
We asked whether Par-1 influences Sqh:GFP foci in border cells (Figures 3B-3D ; Movie S4). Sqh:GFP was more diffuse and fewer foci formed in Par-1 RNAi border cells. The foci that formed had a shortened median lifetime ( Figure 3D ). To determine whether Sqh:GFP foci formed in response to activated Myo-II, we knocked down Rok or expressed a constitutively active form of myosin phosphatase (MbsN300) [30] . In both genotypes, fewer Sqh:GFP foci formed, and they were less persistent (Figures 3C and 3D ; Movie S5; data not shown), suggesting that Sqh:GFP foci dynamics depend on Myo-II activation. Thus, Par-1 regulates the localized formation and/or stability of Myo-II foci in border cells.
Par-1 Regulates the Levels of Activated Myo-II in Border Cells
To determine whether Par-1 influences Myo-II activity in vivo, we examined the levels of activated MRLC/Sqh in border cells. We used an antibody that specifically recognizes MRLC/Sqh when it is phosphorylated at the activating Ser-21 (p-MRLC/ Sqh) [11, 17, 18] . Control border cells expressed high levels of p-MRLC/Sqh at the cell cortex ( Figure 4A ). Border cells in which Par-1 ( Figure 4B ) or the known activator Rok ( Figure 4C ) were knocked down by RNAi had reduced levels of p-MRLC/ Sqh compared to control ( Figure 4D ). In contrast, levels of the cell-junction protein E-cadherin were unaffected ( Figures  4A-4D) . Importantly, the overall levels of endogenous MRLC/ Sqh were unchanged when Par-1 was ubiquitously knocked down ( Figure S3A ). Conversely, Par-1-or Rok-overexpressing border cells had quantifiably higher levels of p-MRLC/Sqh compared to control, but E-cadherin levels were unchanged ( Figures 4E-4H) . Furthermore, Mbs RNAi also significantly increased p-MRLC/Sqh levels ( Figures S3B and S3C) , confirming that myosin phosphatase inhibits Myo-II activation in border cells. Together, these results show that Par-1 promotes phosphorylation and activation of MRLC/Sqh in vivo.
Par-1 Interacts with and Phosphorylates the Myosin Phosphatase Complex
We next investigated the mechanistic basis for how Par-1 controls the levels of activated MRLC/Sqh. Kinases such as Rok activate Myo-II directly by phosphorylating MRLC/Sqh and indirectly by inactivating myosin phosphatase [19, 24, 25] , whereas other kinases, such as NUAK1 and MRCK, primarily inactivate myosin phosphatase [31, 32] . Myosin phosphatase is inhibited by phosphorylation of the myosin binding subunit, Mbs, at several sites including Thr-594 (Thr-696 in mammalian MYPT1) [19, 25] . We did not detect Par-1 and Sqh in a protein complex; GFP-tagged Par-1 or Sqh:GFP did not coimmunoprecipitate the respective endogenous proteins from fly extracts (data not shown). Notably, Par-1 was present in an immunocomplex with myosin phosphatase (Figures 5A and 5B; Figures S4A and S4B ). Endogenous Mbs was immunoprecipitated from S2 cell ( Figure 5A ) and ovarian ( Figure S4A ) lysates with GFP-tagged Par-1. Conversely, endogenous Par-1 was immunoprecipitated with hemagglutinin (HA)-tagged Mbs from S2 cell lysates (Figure 5B) . Flapwing (Flw/PP1b9C; PP1c homolog), a PP1 catalytic subunit that specifically regulates Myo-II [33] , also immunoprecipitated endogenous Par-1 and Mbs from ovarian and whole fly extracts (Figures S4B and S4C ; data not shown).
To test whether Par-1 regulates myosin phosphatase activity, we used an antibody that recognizes phosphorylated Drosophila Mbs at a known inhibitory site (p-T594 Mbs; Figure S4D) [19] . We observed a decrease in p-T594 Mbs levels in ovarian lysates when Par-1 was ubiquitously knocked down ( Figure 5C ). To test whether Par-1 regulates phosphorylation of Mbs, we performed an in vitro kinase assay using immunopurified HA:Mbs as the substrate ( Figure 5D ). Addition of GFP-Par-1 purified from fly lysates or bacterially purified Par-1 catalytic domain [23] increased the levels of p-T594 Mbs in vitro, whereas kinase-dead Par-1 did not ( Figure 5D ). Thus, Par-1 phosphorylates Mbs at the known Thr-594 inhibitory site.
Par-1 Promotes Polarized Distribution of Activated Myo-II in the Border Cell Cluster
Border cells retain epithelial polarity, especially before they detach from the epithelium [8, 10] , with clear basolateral (back) and apical (front) sides. Par-1 localizes to the basolateral side of the cluster ( Figure 6A ) [8] . Although Mbs has a fairly uniform cytoplasmic and cortical localization within the cluster, Mbs overlaps with Par-1 specifically at the basolateral side ( Figure 6A ). In addition, we observed increased Sqh:GFP signal at the basolateral side of the cluster as it detached (Figure 6B) . Fixed wild-type border cell clusters also exhibited polarized enrichment of p-MRLC/Sqh ( Figures 4A, 6C , and 6D). In some cases this biased enrichment was along the axis of migration at both the apical and basolateral sides of the cluster (''front-back bias''), whereas in others it occurred at the sides, perpendicular to the axis of migration (''side bias'') ( Figures 6C and 6D) . The polarized localization of Par-1 led us to ask whether Par-1 contributes to polarized accumulation of p-MRLC/Sqh in border cells before they detach. Although the overall levels of p-MRLC/Sqh were significantly reduced when Par-1 was knocked down (Figures 4B and 4D) , some cortical p-MRLC/ Sqh was still detected ( Figures 6C and 6D) ; however, p-MRLC/Sqh signal was less polarized (''unbiased'') than control ( Figure 6D ). Par-1 overexpression caused a similar unbiased distribution, indicating that overall levels of Par-1 activity are important. In contrast, border cell clusters depleted of Rok by RNAi retained polarized p-MRLC/Sqh, raising the possibility that Rok regulates p-MRLC/Sqh levels, but not its distribution. These results indicate that Par-1 not only regulates the levels of activated MRLC/Sqh but also is important for the polarized enrichment of p-MRLC/Sqh in detaching border cells.
Discussion
Myo-II plays a fundamental role in establishing the front-rear axis of migrating cells to promote directional migration [11] . Myo-II localizes to the cell rear and stimulates motility at the front [34, 35] , likely by local stabilization of adhesions and actomyosin bundles at the cell rear but not at the front [36] . In contrast to single cells, the mechanisms that set up or maintain polarized actomyosin contraction during collective migration are still poorly understood. We identified a new role for Par-1 kinase, namely that Par-1 regulates myosin phosphatase to control Myo-II activation. We propose a model in which Myo-II is activated in a polarized manner (Figures 6E  and 6F ). Myosin phosphatase, which is distributed uniformly in the cluster, is locally inactivated by Par-1 at the basolateral side (back) of the cluster. The consequent polarization of active Myo-II induces contraction and cell morphological changes critical for detachment and motility. The question of how Par-1 becomes localized to the basolateral side of border cells is largely unknown. Phosphorylation by the apical polarity protein aPKC restricts Par-1 to basolateral membranes in epithelial cells [37] and is also critical for Par-1 function in border cells [8] . This mechanism may thus restrict basolateral localization of Par-1 in border cells, although a role for border cell-specific factors cannot be ruled out.
Our observation that there is an increase in Sqh:GFP at the rear of the border cell cluster during detachment is consistent with a specific role for Myo-II in promoting epithelial detachment of border cells. Loss-of-function sqh mosaic clone experiments demonstrated a requirement for Myo-II in border cells and possibly adjacent epithelial follicle cells. Indeed, live imaging analyses revealed that disruption of Myo-II function inhibited the ability of border cells to detach. This raises the question of how Myo-II contributes to detachment. Activation of Rok by Rho GTPase can destabilize cell-cell junctions by inducing actomyosin contraction in normal and tumor-derived epithelial cells [38] . In other contexts, however, Rho-dependent Myo-II stabilizes cell junctions through regulation of the junctional protein E-cadherin [39] . The overall levels of E-cadherin were unchanged when Rok was knocked down in border cells, suggesting that activated Myo-II more likely contributes directly to detachment. We suggest that the localized increase in active Myo-II at the rear specifically contracts the border cell cluster and helps it pull away from the epithelium. In the absence of Par-1, overall levels of activated Myo-II were decreased and Sqh:GFP foci, which correlate with active Myo-II, exhibited altered dynamics; this potentially leads to uncoordinated or decreased contractile forces and thus to defects in detachment.
Par-1 promotes increased p-MRLC/Sqh levels and higher levels of activated myosin by phosphorylation of myosin phosphatase at a known inactivating threonine. Regulated myosin phosphatase activity is essential for many cellular processes, including cell motility and epithelial morphogenesis [19] . Despite identification of kinases that inactivate myosin phosphatase in vitro, few have been shown to do so in vivo during migration. Notably, vertebrate MARK2 (Par-1) phosphorylates the Mbs homolog MYPT1 in vitro at several sites, including the conserved threonine examined here [31] , although this has not been confirmed in vivo. This raises the intriguing possibility that vertebrate Par-1 homologs regulate myosin phosphatase, and thus Myo-II, during cell migration. However, Par-1-mediated regulation of Myo-II phosphorylation via myosin phosphatase may be cell or context specific. In contrast to the situation in border cells, Par-1 does not colocalize with myosin phosphatase in Drosophila ovarian epithelial follicle cells; active p-MRLC/Sqh and Mbs localized to apical domains in follicle cells whereas Par-1 localizes to basolateral membranes [18, 23] (data not shown).
Active Myo-II accumulates at the apical side/front of the border cell cluster in addition to its localization at the rear. Myo-II that is localized near the leading edge of single cells has been proposed to promote retraction by coordinating cell-substrate adhesions with the actin cytoskeleton [40, 41] . Likely roles for Myo-II at apical (front) side of the border cell cluster include retraction of protrusions [20] , as well as resolving protrusion dynamics from the pre-to postdetachment phases of migration (this study). Our data do not explicitly support a role for Par-1 at the apical side of the cluster. Moreover, in the absence of Par-1, we detected a low level of phosphorylated MRLC/Sqh that was still partially localized. Thus, Myo-II is activated by at least one other kinase in addition to Par-1.
We hypothesize that Par-1 promotes higher levels of Myo-II activity at the basolateral side (back), whereas another kinase activates Myo-II (and/or inactivates the phosphatase) specifically at the front. Rok can phosphorylate both MRLC and myosin phosphatase [24, 25] . Knockdown of Rok by RNAi significantly reduced p-MRLC/Sqh levels and disrupted border migration. The combined depletion of both Par-1 and Rok almost completely abolished detachment, suggesting that the two kinases converge (directly or indirectly) on the same target (Myo-II). Epithelial morphogenesis during C. elegans embryonic elongation and Drosophila larval tissue development require multiple kinases to optimally activate Myo-II [42, 43] . Furthermore, different kinases have been shown to regulate MRLC activation at discrete locations within single migrating cells. For example, MLCK phosphorylates MRLC at the front or leading edge, whereas Rok targets MRLC in the cell body and at the trailing edge of fibroblasts [14] . However, it remains to be determined whether Rok and/or additional kinases have a polarized or more general role in Myo-II activation in border cells.
Our study demonstrates that maintaining localized Myo-II activity is a critical feature of collective cell detachment and motility and identifies the conserved polarity kinase Par-1 as a key new regulator of this pathway. Active Myo-II is polarized within the border cell cluster, rather than in individual border cells, emphasizing that asymmetrically activated Myo-II contributes to collective behavior. Notably, in a model of collective cancer cell invasion, high actomyosin activity at cell-matrix contacts combined with low activity at contacts between cells within the group, produced optimal contractile force around the outside and thus promoted collective cell movement [44] . It will be important to determine whether vertebrate Par-1 homologs also regulate actomyosin contraction during processes that depend on collective cell motility, such as wound healing or tumor invasion and metastasis. Given that many metastasizing tumors detach from epithelia both as single cells and collective groups, it will be important to further probe the mechanisms of myosin-mediated contraction in this process.
Experimental Procedures
Drosophila Genetics
Crosses were performed at 25 C, except tsGAL80 crosses were performed at 18 C. Flies were incubated at 29 C for R14 hr before dissection for optimal GAL4/UAS transgene expression. Strain information is in the Supplemental Experimental Procedures. GAL4 lines outcrossed to w RNAi (tsGAL80). Mosaic mutant clones of sqh AX3 [17] and rok 2 [15] were generated with the FLP/FRT system using flies of the genotype ubimRFP.nls, hsFLP, FRT 19A.
Immunofluorescence and Live Imaging
Ovary dissection and staining methods were performed as described [8] . Fixation was in 4% formaldehyde in phosphate buffer (pH 7.4) for 10 min; for p-MRLC/Sqh staining, ovaries were fixed in 8% formaldehyde in PBS for 5 min. The following primary antibodies were used: rat anti-DE-cadherin 1:25 (DCAD2; Developmental Studies Hybridoma Bank, DSHB); mouse anti-a-tubulin 1:400 (DM1A, Sigma); guinea pig anti-Par-1 1:10 [8] ; rabbit anti-Mbs 1:1000 (from C. Tan); rabbit anti-pSer19 MRLC 1:10 (p-MRLC/ Sqh; Cell Signaling Technologies). Secondary antibodies or phalloidin (to label F-actin) conjugated to Alexa Fluor 488 or Alexa Fluor 568 (1:400; Invitrogen) were used. DAPI (0.05 mg/mL; Sigma) was used to stain nuclei.
Ovary dissection, live culturing, and time-lapse imaging were performed as described [7] . Imaging was performed on a Zeiss AxioImager Z1 motorized upright microscope with a Zeiss Colibri LED light source (live imaging), or HXP 120 light source and the ApoTome system (fixed samples), and a Zeiss AxioCam MRm CCD camera controlled with AxioVision 4.8.2 software. Movie S1 and Movie S2 were acquired using 75%-100% LED power (LED module 540-580 nm) at 3 min intervals for 4-5 hr, using either a Plan-Apochromat 20 3 0.75 numerical aperture (NA) or a Plan-Apochromat 10 3 0.45 NA objective. For Movie S4 and Movie S5, time-lapse images were captured using 25% LED power (LED module 455) at 10 s intervals for 30 min, and 10 z stacks were acquired at 0.5 mm intervals using a PlanNeofluar 40 3 1.3 NA oil objective. For Movie S3, images were acquired on a Nikon TE-2000 microscope using a 20 3 0.75 NA objective and the PerkinElmer UltraVIEW VoX spinning disk confocal with a Hamamatsu cooled 14-bit EMCCD C9100-50 camera controlled by PerkinElmer Volocity software. Descriptions of the image analyses are in the Supplemental Experimental Procedures.
Immunoprecipitation, Western Blot Analysis, and In Vitro Kinase Assays For immunoprecipitations, samples were lysed in homogenization buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2.5 mM EDTA, 0.1% Triton X-100) supplemented with Halt protease and phosphatase inhibitor cocktail (Thermo Scientific). Five micrograms of antibody IgG (rabbit anti-GFP or anti-HA; Invitrogen) per milligram of magnetic Dynabeads Protein A (Invitrogen) were preincubated before adding lysate. Lysate was added to antibody-bound beads and incubated at 4 C overnight, washed in homogenization buffer, and prepared for SDS-PAGE followed by western blot analysis using standard protocols. In vitro kinase assays were performed as described [45] on isolated HA:Mbs protein using purified Par-1 kinase. Details on sample preparation, antibodies, and western blotting are in the Supplemental Experimental Procedures.
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